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Abstract. We describe 70 cases of monocled cobra (Naja kaouthia) bite admitted to Chittagong Medical College
Hospital, Bangladesh. The biting snakes were identified by examining the dead snake and/or detectingN. kaouthia venom
antigens in patients’ serum. Bites were most common in the early morning and evening during the monsoon (May–July).
Ligatures were routinely applied to the bitten limb before admission. Thirty-seven patients consulted traditional healers,
most of whommade incisions around the bite site. Fifty-eight patients experienced severe neurotoxicity andmost suffered
swelling and pain of the bitten limb. The use of an Indian polyvalent antivenom in patients exhibiting severe neurotoxicity
resulted in clinical improvement but most patients experienced moderate-to-severe adverse reactions. Antivenom did
not influence local blistering and necrosis appearing in 19 patients; 12 required debridement. Edrophonium significantly
improved the ability of patients to open the eyes, endurance of upward gaze, and peak expiratory flow rate suggesting that
a longer-acting anticholinesterase drug (neostigmine) could be recommended for first aid. The study suggested that
regionally appropriate antivenom should be raised against the venoms of the major envenoming species of Bangladesh
and highlighted the need to improve the training of staff of local medical centers and to invest in the basic health
infrastructure in rural communities.
INTRODUCTION
The venomous snake fauna of Bangladesh remains poorly
characterized, but clinical reports from the regions of
Chittagong, Cox’s Bazaar, Khulna, Rajshahi, and Mymensingh
have described neurotoxic envenoming, a life-threatening
medical emergency that requires treatment with specific
antivenom and assisted ventilation in cases of respiratory
paralysis.1–8 In Asia and Africa, envenoming by some cobra
species is associated with substantial local soft tissue damage
requiring surgical debridement often leading to prolonged
hospitalization, scarring, malignant transformation, and
potentially permanent disability.9–14 The present study of bites
by monocled (monocellate) cobras, Naja kaouthia (Figure 1A
and B), forms part of a large prospective study of snakebite in
Chittagong Division, Bangladesh. This division located in
southeastern Bangladesh, covers an area of 33,771 km2 with a
population of approximately 28 million. The study was based
at Chittagong Medical College Hospital (CMCH), the major
tertiary care referral hospital for the Division and was carried
out between May 1999 and October 2002. Most patients were
received from Chittagong, Cox’s Bazaar, and the three
Chittagong Hill Tracts districts. We hoped to define, more
precisely, the clinical phenotype of envenoming, assess
antivenom use and provide a rational basis for defining
national strategies required to improve medical care. Eight
hundred and eighty-four patients with a credible history and
signs and symptoms of snakebite envenoming were admitted.
Of the 884 patients, 70 were identified as victims of bites by
N. kaouthia by examining the snake responsible, if brought to
the clinic, and/or by the detection of the specific venom
antigens in the patient’s serum. Here, we describe the
epidemiology, prehospital treatment, clinical assessment,
management, and outcomes of these 70 patients.
MATERIALS AND METHODS
Case history. A full case history was completed for each
patient, including personal and epidemiological data and
details of prehospital treatment, using a standard pro forma.
Physical signs consistent with snakebite (fang marks, oozing
of blood from putative fang punctures, localized pain, and
swelling) were recorded. Evidence of bleeding from old
wounds as well as spontaneous bleeding from the gums and
external orifices, and bloody sputum, feces, or urine was
noted. A neurological examination was made to detect signs
of neurotoxicity (such as bilateral ptosis, external ophthal-
moplegia, dysphagia, dysphonia, reduced grip strength, weak
neck muscles, and “broken neck sign”) and/or myotoxicity
(such as muscle pain or tenderness and elevated serum
creatine kinase). The ability to open and close the mouth, to
protrude the tongue, and to cough was assessed, as well as
chest movements, respiratory difficulty, pooling of oral
secretions in the oropharynx, and breathlessness. Blistering
and necrosis near the site of the bite were recorded. Blood
pressure and heart rate were routinely measured. Venous
blood samples were collected for hematological measure-
ments and coagulability testing using the 20-minute whole
blood clotting test (20WBCT).15,16
Antivenom administration. Haffkine polyvalent anti-
venom (raised against the venoms of Naja naja, Bungarus
caeruleus, Daboia russelii, and Echis carinatus sourced
mainly from Mamallapuram, Tamil Nadu, India) was
*Address correspondence to John B. Harris, Medical Toxicology
Centre and Institute of Neuroscience, Newcastle University,
Newcastle upon Tyne, NE2 4HH, United Kingdom. E-mail: j.b.
harris@ncl.ac.uk
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administered to all patients exhibiting signs of advanced
systemic neurotoxicity (e.g., bilateral complete ptosis, external
ophthalmoplegia, dysphagia, dysphonia, weak grip strength,
weak neck muscles, “broken neck” sign, or respiratory
difficulty). Antivenom was not given to patients with minimal
signs of neurotoxicity (e.g., partial ptosis with no other signs of
systemic neurotoxicity) or to those with local signs of
envenoming (e.g., blistering and local necrosis) in the absence
of systemic neurotoxicity. Antivenom use conformed to
Bangladeshi national guidelines: 100 mg of immunoglobulin in
100 mL vehicle was made up to 200 mL in 0.9% w/v NaCl as
directed by themanufacturer and administered via intravenous
infusion over a period of 1 hour. In the absence of any reversal
of paralysis after 2 hours, the same dose was repeated.
Infusion was suspended if a patient developed adverse
responses (e.g., urticaria, anaphylaxis, severe pyrogenic side
effects) before the infusion was completed. In that event,
adrenaline (0.25 mg i.m.), (0.2 mg/kg i.v.), and hydrocortisone
(2 mg/kg i.v.) were administered and the infusion of antivenom
was resumed.
Ventilatory support. Ventilatory support was provided to
those patients exhibiting cyanosis, sighing respiration, or other
signs of ineffective ventilation. Support waswithdrawn as soon
as adequate spontaneous respiration was reestablished and
the patient resisted enforced ventilation.
Detection of venom antigen in the serum of patients.
A micro enzyme-linked immunosorbent assay technique
(micro-ELISA) was used to detect venom antigens in the serum
of the bitten patients.17,18 Microtiter assay plates were coated
with rabbit anti-N. kaouthia IgG as the antigen capture system.
This enabled the formal identification of the biting snake and
also the calculation of venom antigen concentration in the
serum from a standard venom concentrations curve ranging
from 0.1 to 500 ng/mL in phosphate-buffered saline (PBS; pH
7.2) containing 1% v/v normal rabbit serum. Specificity
was confirmed using the venoms of four major biting species
in Bangladesh (B. caeruleus, N. kaouthia, Trimeresurus
albolabris). The lower limit of detection was 0.5 ng/mL. Venom
antigen data were subsequently reconciled with previously
collected clinical records by J. B. Harris. Urine was examined
for the presence of albumin and/or erythrocytes.
Effect of N. kaouthia venom on blood coagulation. A
lyophilized, pooled sample of the venom of N. kaouthia from a
fully documented venom collection held by the Venom
Research Unit, Liverpool School of Tropical Medicine, was
used to determine the effects of the venom on activated partial
thromboplastin times (APTT) and thromboelastography (TEG)
under controlled laboratory conditions. A pooled sample of the
venom of Pseudechis papuanus from Papua New Guinea was
used as a positive control. Venom samples were stored at
−80°C until reconstituted for use in PBS (pH7.2) and aliquots
of 50 μL were stored at −80°C. When required, the venom was
thawed at 37°C then placed on ice for the duration of the
experiment. Serial dilutions of venom were made in PBS to
provide venom concentrations ranging between 35 and
4,436 ng/mL.
Control blood samples for measuring the effects of the
venoms on APTT and TEG were obtained from 10 healthy
volunteers (five females, age range 22–52 years; five males,
age range 23–50 years) and collected into 0.105 M sodium
citrate. Plasma, obtained by centrifugation of the citrated
blood (1,780 × g) for 10 minutes, was pooled before use.
The effects of snake venom on human blood coagulation
were evaluated using the Amelung KC4 (Trinity Biotech PLC,
Wicklow, Ireland). Briefly, 100 μL of citrated human plasma
was introduced to the KC4 cup, followed by 100 μL of IL
Hemosil APTT reagent (Instrumentation LaboratoriesCompany,
Bedford, MA) and 10 μL of appropriately diluted snake venom
and the mixture incubated for 220 seconds. Clotting was
triggered by the addition of 100 μL 0.02 mol/L CaCl2
FIGURE 1. (A) Monocled cobra (Naja kaouthia) from southeastern Bangladesh with snake handler. (B) Naja kaouthia from Kolkata, West Bengal,
India. Note the variation in the pattern of themonocular hoodmarkings between A andB. (C) Spectacled cobra (Naja naja) fromKolkata,West Bengal,
India, showing the distinctive “pair of “spectacles”.
877COBRA BITES IN BANGLADESH
(Instrumentation Laboratories Company, Bedford, MA) and
the clotting time recorded.
TEG analysis was performed using a TEG 5000 Homeo-
stasis analyzer (Hemonetics Corporation, Braintree, MA).
Blood was collected from healthy volunteers into 0.105 M
sodium citrate tubes, mixed, and then allowed to stand at
room temperature for 30 minutes before testing. All TEG tests
were performed within 2 hours of venepuncture. To test the
effects of venoms on the TEG, 10 μL of appropriately diluted
snake venom was added to the incubation cup together with
20 μL of 0.2 MCaCl2. Onemilliliter of citrated bloodwas added
to a vial containing kaolin (Haemonetics Corporation). The
kaolin/bloodmixture (330 μL) was added to the incubation cup
and the resulting TEG trace was recorded for 45–60 minutes.
Each experiment was completed three times on different
samples of plasma/blood as appropriate.
The Tensilon® test. A Tensilon® (edrophonium) test was
used in a separate group of 18 randomly recruited cobra
bite patients exhibiting clinical signs of neurotoxicity. A ran-
domized, double-blind, crossover design was used, each
patient serving as his or her own control. Whether edroph-
oniumor placebo (the corresponding volume of NaCl 0.9%w/v)
was to be administered first was determined by lottery; neither
observer nor patient knew which was being given. Atropine
sulfate (0.6 mg i.v.) was given to all patients beforehand. Either
edrophonium (10 mg i.v.) or placebo was given immediately
afterward by intravenous infusion over 2 minutes. Thirty
minutes later patients received, in reverse order, either edroph-
onium or placebo as required. The duration for which a patient
could retract the eye lids, the area (%) of the iris exposedwhen
a maximal effort was being made to open the eyes, the ability
to open the mouth, peak expiratory flow rate (PEFR), and the
maximum pressure generated by the patient when trying to
blow into a manometer were measured every 5 minutes for
20 minutes after the administration of edrophonium or
placebo. One patient had received antivenom before the
initiation of the test, two were given antivenom during the test,
and 14 were given antivenom after the completion of the test.
A single patient for whom antivenom was unavailable was
maintained on neostigmine, 50 mcg/kg body weight sub-
cutaneously every 4 hours following the completion of a posi-
tive edrophonium test, until the neurotoxic signs disappeared.
Ethical considerations. All patients, or a close relative
where necessary, gave written informed consent for the
inclusion, in public, academic, and professional presentations
and publications, of personal, circumstantial, clinical, and
laboratory information, including photographic and radio-
logical images relating to medical advice, diagnosis, and
treatment received by the patient at CMCH. Standardized data
forms containing all personal data, including details of
treatment, were securely stored at CMCH. These forms were
exclusively available to clinical staff directly involved in the
care of the patients. Anonymized data associated only with
a patient ID number were stored electronically in an
SPSS database that was available to all involved with the
research project.
Statistical analysis. Numerical data are given as mean ±
standard error or as median and range as appropriate. Data
were analyzed using SPSS version 21 software (SPSS Inc,
Chicago, IL). Differences between different data sets were
calculated using Students’ t test or the Mann–Whitney test as
appropriate. P < 0.05 was considered indicative of statistical
significance. Tests for correlations between two independent
sets of data weremade using Pearson’s test.
RESULTS
Case studies. Case 1: A 7-year-old girl from Azimpur vil-
lage, Patiya Upazilla (subdistrict), was bitten on her left ankle at
home at 10:00 PM by a “blackish/yellowish snake” approxi-
mately 68 cm long. The snake was caught, killed, and
eventually brought to CMCH where it was formally identified
as “zhawra,” the local name for a monocled cobra,N. kaouthia,
based on the distinctive single eye marking on the dorsal
surface of the hood. The patient reported immediate pain and
there was localized bleeding at the bite site. She was taken
without delay to a traditional healer, locally known as an ohza,
ozha, ojha, or bede, who applied three ligatures proximal to the
bite site, two on the calf and one on the thigh. The bite site was
incised and she was given a herbal infusion to drink. She was
admitted to CMCH between 3 and 4 hours after the bite.
Ligatures were released and amoxicillin (10 mg/kg i.v.) and
neostigmine (50 μg/kg s.c.) were administered. The pulse rate
was 104 beats/minute and blood pressure 105/80mmHg. Two
fang marks, 10 mm apart, were identified. The patient felt faint
and generally weak and had difficulty in swallowing and
speaking. Five hours after the bite, neurological signs
predominated with complete bilateral posies, external ophthal-
moplegia, an inability to open or close the mouth or protrude
the tongue, a “broken neck” sign, a weak grip, and depressed
reflexes. Peak flow was 100 L/minute. Total white cells (15 ×
109/L cf. reference range 4–11 × 109/L) and polymorphs (82%
cf. reference range 20–40%)were elevated, but platelet counts
and hemoglobin concentrationswere within normal limits.
Antivenom (Haffkine polyvalent 100 mg in 200 mL) was
infused intravenously. Neurotoxic signs began to diminish
after 35 minutes. Adverse reactions to antivenom (urticaria,
cough, wheezing, and angio-edema of the lips and tongue)
were treated with adrenaline (0.25 mg i.m.), chlorphenamine
(0.2 mg/kg i.v.), and hydrocortisone (2 mg/kg i.v.). Albumin
(concentration not recorded) was detected in the urine but
there were no erythrocytes or casts. Electrocardiogram was
normal. By 2 days after the bite, all neurotoxic signs had
resolved but a small area (∼3 cm diameter) of blistered,
necrotic tissue appeared. The blister was aspirated and
necrotic tissue debrided. The patient was discharged
8 days after admission. The circulating concentration of
N. kaouthia venom antigen was 3.9 ng/mL.
Case 2: An 18-year-old agriculture worker from Raojan was
walking along a drainage ditch at 7:00 PM. Hewas bitten on the
dorsal aspect of the right foot by a “blackish snake,
approximately 120 cm long and 3 cm in diameter,” which
he identified as “zhawra.” Three ligatures were applied
immediately, two to the bitten leg and one to the thigh. The
bite site was not incised and no herbal remedies were used.
Hewas not seen by a traditional healer. He did not vomit or feel
faint but developed weakness and drooping eyelids 1 hour
after the bite, and had difficulty in speaking and swallowing
after 90minutes. Within 2 hours, he developed neck weakness
and passed scanty, highly colored urine. At 2.5 hours, he
complained of breathlessness. He was admitted to CMCH
3 hours after the bite. Pulse rate was 120 beats/minute and
blood pressure 110/70 mmHg. There were two fang puncture
marks, 15 mm apart, to the dorsum of the right foot. Bilateral
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ptosis was complete and was accompanied by external
ophthalmoplegia, the “broken neck” sign, weak grip and
depressed tendon reflexes, an inability to open or close the
mouth or protrude the tongue, pooled saliva, and an absent
gag reflex. Peak flow could not be recorded and assisted
ventilation was startedwithin 1 hour of admission. Hewas then
treated with cephradine (500 mg/kg orally), metronidazole
(7.5 mg/kg orally), neostigmine (50 mcg/kg s.c.), and atropine
(0.6 mg i.v.). An infusion of antivenom (Haffkine polyvalent,
100 mg in 200 mL) was given in two doses. The first dose,
given at 4–5 hours postadmission, was followed within
30minutes by an anaphylactic reaction that wasmanagedwith
adrenaline (0.25 mg i.m.), chlorphenamine (0.2 mg/kg i.v.), and
hydrocortisone (2 mg/kg i.v.). There was no positive response
to the antivenom and the dose was repeated at 7 hours after
further treatment with adrenaline. The patient remained on
continuous assisted ventilation but was unresponsive until his
death 7 days after admission. Immediately before death,
oxygen saturation fell to 21% and he had an episode of
status epilepticus. The cause of death was recorded as
hypoxic encephalopathy.
Laboratory data confirmed elevated total white cell counts
(16 × 109/L cf. reference range 4–11 × 109/L and polymorphs
(85% cf. reference range 20–40%). Platelet counts were within
normal limits. Hemoglobin concentration was below the lower
level of the reference range (13 g/dL cf. reference range
14–18 g/dL). Serum creatine kinase was elevated (1,076 units/L
cf. 150–200 units/L in normal subjects). The circulating
concentration of venom antigen was 244.6 ng/mL.
Epidemiology. The average age of the patients was
29 years (median = 26 years, range 3.5–85 years) and the
male/female ratio was 1.9:1. Thirty-six percent of patients were
students, 26% were housewives/domestic workers, and 20%
were engaged in agriculture. No bites were recorded during
the coolermonths of December, January, and February. There-
after, bites became more common with rising temperatures
and humidity to peak during the monsoon period of May–July.
All patients were bitten on the limbs, typically below the knee
or elbow. Bites were most common between 5:00 AM and
12:00 PMor 3:00 PM and 11:00 PM andpeak timeswere between
6:00 AM and 10:00 AM and between 6:00 PM and 7:00 PM.
Only 12% of patients were asleep at the time of the bite.
Prehospital treatment. All 70 patients had ligatures
(mean = 3, range 1–6) applied proximal to the bite site. Thirty-
seven of the patients had visited a traditional healer before
admission to CMCH. The typical consultation lasted between
1 and 2 hours, but in four cases lasted for > 10 hours. All
patients visiting a traditional healer were incised at the site of
the bite and 25 of them had been given a herbal infusion of
unknown composition to drink. Mud and herbs were
occasionally applied to the bite site but details of these
practices were not formally collected. In only one case
was the bitten limb immobilized and a pressure bandage
was applied.19
Clinical assessment and management. Patients were
admitted to CMCH between 1 and 27 hours (median 7 hours)
after the biting incident and ligatures were slowly released.
Tetanus toxoid and amoxicillin were given to 63 patients and
neostigmine to 57 of them. Visible fang punctures/scratches
could be identified in 32 of the 70 patients admitted. There was
slight bleeding at the putative bite site in only five of them.
Neither persistent bleeding from the bite site nor bleeding from
any remote site was seen in any patient. Blood pressure was
unremarkable in all patients. Swelling, localized to the bitten
limb was seen in 53 patients, and pain at the bite site, reported
by 42 patients, was transient and was treated with para-
cetamol, diclofenac, or ibuprofen as required. Lymph node
tenderness and swelling was seen in 17 patients.
One patient, who had been bitten on the foot, brought the
offending snake to the clinic. It was positively identified as
N. kaouthia. The patient developed no neurotoxicity or local
blistering and necrosis and she was discharged 48 hours after
the bite. Subsequent analysis confirmed the absence of
venom antigen in her serum. It was concluded that she had
received a bite without the injection of venom. The other
69 patients were all envenomed. Nonspecific signs/symptoms
included vomiting, seen on admission in 43 patients and
fainting experienced by 10 patients. Neurotoxic signs present
on admission included bilateral ptosis (58 patients Figure 2A),
difficulty in speaking (52), generalized weakness (49), weak
neck muscles (44), difficulty in swallowing (41), blurred vision
(29), breathlessness (23), and cyanosis in three (Table 1). No
patient presented with or developed generalized muscle
tenderness or pain. Swelling of the bitten limb (Figure 2B) was
seen in 53 patients. Localized blistering and necrosis of the
skin at or close to the bite site (Figure 2C) appeared during day
1 in four patients, thereafter increasing to six by day 2, nine by
day 3 to peak at 19 by day 5. In three patients, there was local
blistering with no signs of systemic neurotoxicity, and in one
patient the blister first appeared 5 days after admission. Surgi-
cal debridement of necrotic skin was required in 12 patients.
Antivenom was used in all 58 patients exhibiting signs
of advanced neurotoxicity (e.g., bilateral ptosis, external
ophthalmoplegia, “broken neck” sign, cranial neuropathy). One
patient received 50 mg of antivenom and one patient received
200 mg in two divided doses. All others received a single dose
of 100 mg as described in Materials and Methods section.
There was clinical improvement in 51 patients, with complete
resolution of ptosis, difficulties with speech and swallowing,
and general neck weakness within 1 hour in some cases but
on average by 5–6 hours after the initiation of treatment. In
4 cases, there was no further deterioration but neurotoxic
signs continued for up to 30 hours and breathlessness for up
to 50 hours. There was a continuing deterioration in the
condition of three patients, and two of those three patients
succumbed, one to hypoxic encephalopathy (see Case 2
above) and one to cardiorespiratory failure; the latter patient
had a previous history of cardiovascular problems. It is signifi-
cant to note that blistering and localized skin necrosis
appeared in 16 patients already treated with antivenom.
Eleven patients required assisted ventilation: four were
ventilated for 2 hours or less, five for up to 24 hours, one for
36 hours, and one (see Case 2 above) for 7 days.
Laboratory tests. Hematological data are summarized in
Table 2. Total white cell counts were elevated in > 80% of
patients and the proportion of polymorphs was elevated in
> 98% of patients. Hemoglobin concentrations were low in the
majority of both male and female patients. All other
hematological data (including basophile, eosinophil, and
platelet counts) were similar to the accepted normal reference
range for Bangladesh (CSCR), Chittagong, Bangladesh: Total
leukocyte count: 4.0–11 × 109/L, differential leukocyte counts:
neutrophils 45–70%, lymphocytes 20–40%,monocytes 2–5%,
eosinophils 1–6%, basophils 0–1%, platelets 150–400 × 109/L,
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cyanmethemoglobin (hemoglobin) ♂ 14.0–18.0 g/dL, ♀
12.0–16.0 g/dL). The presence of albumin in the urine was
detected in 46% of patients and erythrocytes were present in
22%. Therewere no other signs of renal complications.
The 20WBCT was negative (i.e., blood clotted within
20 minutes in a glass vessel at ambient temperature) in all
but two patients.
APPT was not increased by concentrations of N. kaouthia
venom up to 4,436 ng/mL (laboratory normal reference range
30–45 seconds; in the presence of 4,436 ng/mL venom:
34.5 ± 0.55 seconds, N = 10). Similarly, there were no
significant changes in any of the parameters comprising TEG
except for an insignificant fall in the α angle (signifying a small
reduction in the rate of clot formation) at venom concentrations
between 277 and 555 ng/mL. Pseudechis papuanus venom
served as a positive control; APTT increased rapidly with
increasing concentrations of venom from 3.8 ± 0.21 seconds
(N = 10) at a concentration of 35 ng/mL to 64.6 ± 2.7 seconds
at 277 ng/mL, and 241.7 ± 11.6 seconds at 4,436 ng/mL.
Pseudechis papuanus venom also caused a slowing of the
initiation of the clotting process R, and a reduction in the
kinetics of clotting and clot formation (K and α angle). There
was no change in the ultimate strength of the clot, MA, or the
rate of breakdown of the clot that formed, G (see Figure 3).
Serum venom antigenemia levels. Venom antigenemia
was calculated in 65 patients. One patient with a proven bite
but no clinical signs of envenoming had no detectable venom
antigenemia. In the other 64 patients, venom antigenemia
ranged between 3.5 and 496.5 ng/mL (mean = 99.3,
mode 49 ng/mL). There was no correlation between venom
antigenemia and either the age or gender of the patient. There
was a clear relationship between venom antigenemia and the
clinical severity of envenoming. Thus, in five patients with only
incomplete ptosis but without any respiratory difficulty, no
difficulty with speech or swallowing, and no neuromuscular
weakness, and for whom antivenom was deemed unneces-
sary, venom antigenemia ranged between 3.5 and 24.3 ng/mL
(mean 13.4 ± 3.6). In those with severe neurotoxicity but no
local necrosis, venom antigenemia was significantly higher
(mean 103.2 ± 16.6; N = 39; P < 0.05). Those with both
severe neurotoxicity and local tissue necrosis had a similarly
high venom antigenemia (mean 119.2 ± 35.2; N = 20). The
two patients who died as a result of envenoming had
venom antigenemias of 244.6 and 260.8 ng/mL, respectively.
There was a positive correlation (P < 0.05) between venom
antigenemia and the duration of hospitalization (Figure 4),
but no relationship between venom antigenemia and the
appearance of localized blistering and necrosis. Adverse
reactions to antivenom were experienced by 68% of patients
treated with antivenom. In all but one patient, in whom the
FIGURE 2. (A) Bilateral ptosis, typically the first sign of neurotoxicity following snakebite envenoming, was seen in 58/70 patients bitten by
Naja kaouthia in southeastern Bangladesh. (B) Swelling extending above the elbow and early demarcated hyperpigmentation at the site of the
bite over the proximal phalanx of the right index finger and over the dorsum of the hand. (C) Skin necrosis was seen in 19/70 patients in this
series. Note advanced superficial necrosis and de-roofed blister following a bite on the dorsum of the foot.
TABLE 1
Neurological signs of envenoming by Naja kaouthia in 70 patients
in southeastern Bangladesh
Neurological signs of envenoming
Sign Frequency (%)
Duration (hours)
mean (maximum)
Ptosis 83 5 (50)
Dysarthria 75 4.5 (30)
Weak neck 64 5 (45)
Difficulty swallowing 59 4 (20)
Blurred vision 42 5 (30)
Double vision 30 6 (35)
Breathlessness 30 7 (50)
Cyanosis 4 n/a
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antivenom use was abandoned due the severity of the adverse
response, adverse reactions were successfully managed with
adrenaline (0.25 mg i.m.), chlorphenamine (0.2 mg/kg i.v.), and
hydrocortisone (2 mg/kg i.v.).
The Tensilon® (edrophonium) test. The test was used in
a separate group of 18 patients with neurotoxic envenoming
followingmonocled cobra bite. The ability to open the eyes (as
reflected in the percentage of iris uncovered) in all 18 patients
was significantly improved after the administration of
edrophonium. The improvement was first seen 5 minutes after
administration when the percentage of iris exposed increased
to 49% ± 6.5%, compared with 33% ± 5.4% after placebo.
The improvement lasted until 15 minutes after edrophonium,
when the area of iris exposed was 45% ± 7.0%, compared
with 31% ± 5.6% after placebo (P < 0.001). The improvement
of the function of the elevator palpebrae superioris muscle was
also reflected in the improvement of endurance of upward
gaze, over the same time period. Edrophonium also produced
a statistically significant improvement in PEFR, the ability to
generate pressure while blowing into the disconnected tube of
a blood-pressure manometer, and the ability to open the
mouth 5 minutes after administration. The data are summa-
rized in Table 3.
Discharge from hospital. Patients were discharged from
CMCH when attending clinicians considered them to be
sufficiently recovered from their experience and were clini-
cally stable.
DISCUSSION
A nation-wide community-based survey of snakebite in rural
Bangladesh estimated that 589,919 individuals were bitten
each year and that 6,041 of those bites were fatal.20 Most fatal
snake-bite cases in Bangladesh bites are considered to be
attributable to neurotoxic envenoming by cobras (Naja spp.)
and kraits (Bungarus spp.). Differentiation between cobra and
krait bites on admission to a clinical facility is important
because they require different strategies for successful
treatment.8 The determination of the biting species is
obviously straightforward if the snake responsible is brought
to the clinic with the patient. Usually, however, the physician
will have to consider the clinical syndrome and the cir-
cumstantial evidence of the biting incident before making a
decision on themost appropriate treatment for the patient.8,21
The present study of 70 patients bitten by monocled cobras
(N. kaouthia; Figure 1A and B) is the largest and most detailed
study of envenoming by this species published so far. The
identity of the biting snake was established in every case,
either by examining the dead snake or by the retrospective
detection of venom antigens of N. kaouthia in the patient’s
serum using ELISA.22–24 The only other species of cobra
known to be present elsewhere in Bangladesh is the specta-
cled cobra, N. naja (Figure 1C). The venom of this species
could theoretically cross-react in the ELISA test. However, no
specimen of N. naja could be located in any natural history or
other zoological unit in southeast Bangladesh and no
specimens had been obtained from the catchment area of
CMCH during decades of clinical and field research. It is not
recognized by local expert zoologists, or snake collectors as
being a part of the local fauna.
Bites by the monocled cobra were least common during the
cool and dry months of November–January, becoming
progressively more common as temperature and humidity
rose to peak during the monsoon season of May–July. The
monocled cobra is crepuscular and biting incidents were
particularly common during the early morning and evening and
rare between 11:00 AM and 3:00 PM and during the night. Tight
ligatures were routinely applied to the bitten limb by traditional
healers or by colleagues/family members of the patients. Many
patients had multiple incisions inflicted around the bite-site
FIGURE 3. Stylized thromboelastography trace illustrating information available. R = latent period preceding activation of clot formation. K = α
angle. Rate of clot formation ismeasured 20minutes after the initiation of clotting.MA= clot strength.
TABLE 2
Average hematological data from 70 patients bitten byNaja kaouthia in
southeastern Bangladesh compared with the Bangladeshi national
reference range
Hematological data
Cell type Reference range Patients
Total white cells 4–11 × 109/L 7–10 × 109/L
Monocytes 2–5% 1–9%
Basophils 0–1% 0%
Eosinophils 1–6% 0–10%
Polymorphs 20–40% 23–90%
Platelets 150–400 × 109//L 170–380 × 109/L
Hemoglobin Female 12–16 g/dL 7.5–13.7 g/dL
Male 14–18 g/dL 5–14.5 g/dL
881COBRA BITES IN BANGLADESH
with nonsterile knives and pieces of glass. In some cases
stones, herbs and soil had been applied to the bite site. All
these treatments pose a risk of secondary infection and there
is a lesser but real risk of infection by the snake’s oral
bacteria.25,26 For these reasons, all snake-bite patients
admitted to CMCH were routinely treated with tetanus toxoid
and antibiotics.
Severe neuromuscular weakness associated with enven-
oming was typically reversed, within 5–6 hours, by treat-
ment with the only available antivenom (Indian Haffkine
polyvalent antivenom). The complete restoration of spon-
taneous respiration in those requiring assisted ventilation was
slower but in most cases was achieved within 24 hours.
The administration of antivenom did not prevent the later
development of local blistering and soft tissue necrosis. The
majority of patients receiving the Haffkine® antivenom expe-
rienced undesirable adverse responses including, urticaria,
pyrogenesis and, in one case, anaphylaxis that resulted
in the cessation of antivenom administration.27 The Indian
Haffkine® polyvalent antivenom used in Bangladesh is not
prepared using the venoms of local, medically important
envenoming species in Bangladesh and it is unlikely that it is
effective in neutralizing the effects of the necrotizing factors
present in the venom of N. kaouthia. It is clear that regionally
appropriate antivenoms for use in Bangladesh should be raised
against the venoms of themajor local envenoming species.
Several studies of patients bitten by either viperid or elapid
snakes have demonstrated a correlation between circulating
venom antigen concentration at the time of admission to
hospital and the severity of the clinical syndrome.23,24,28–33
However, a study of bites by the Australian red-bellied black
snake, Pseudechis porphyriacus, demonstrated no correlation
between peak venom antigen concentration and clinical
severity of envenoming.34 We identified several patients bitten
by N. kaouthia with minimal signs of either local or systemic
envenoming. One patient, for example, displayed a partial
ptosis for 24 hours and a small blister developed at the bite site
5 days after the initial incident. He was not treated with
FIGURE 4. Relationship between venom antigen concentration in the patients’ sera and treatment duration in hospital of 70 patients bitten
byNaja kaouthia in southeastern Bangladesh. The Pearson correlation coefficient was 0.05 and the relationshipwas statistically significant (P < 0.05).
TABLE 3
Responses to Tensilon® in 18 patients bitten by Naja kaouthia in southeastern Bangladesh
Time (minutes)
Ptosis (% iris exposed) Eye lid retraction (duration: seconds) Inter-dental cleft (cm) Peak expiratory flow rate (L/minute) Blow pressure (mmHg)
Control Tensilon Control Tensilon Control Tensilon Control Tensilon Control Tensilon
0 34 ± 5.5 41 ± 5.7 9 ± 1.7 18 ± 3.6* 3.9 ± 0.19 4.1 ± 0.16 49 ± 19 58 ± 17 5.9 ± 2.4 7 ± 2.4
5 33 ± 5.4 49 ± 6.5* 11 ± 1.9 22 ± 5.2* 3.8 ± 0.18 4.1 ± 0.15* 60 ± 19 67 ± 20 6.4 ± 2.4 8.7 ± 3.2*
10 31 ± 5.6 50 ± 6.7* 9 ± 1.6 17 ± 2.0* 3.9 ± 0.18 4.1 ± 0.15 47 ± 20 70 ± 15* 6.6 ± 2.4 8.1 ± 3.1
15 30 ± 5.8 45 ± 7.0* 10 ± 1.8 14 ± 2.3 3.8 ± 0.19 4.0 ± 0.18 54 ± 19 66 ± 20 6.1 ± 2.6 7.8 ± 2.3
20 28 ± 5.1 35 ± 6.1 8 ± 1.5 10 ± 1.8 3.8 ± 0.13 3.8 ± 0.19 44 ± 16 55 ± 20 5.8 ± 2.3 6.8 ± 2.6
All patients were pretreated with atropine sulfate (0.6 mg i.v.). Either Tensilon® (10 mg i.v.) or placebo (normal saline) was given immediately after pretreatment by intravenous infusion over
2 minutes. Thirty minutes later patients received, in reverse order, either Tensilon® or placebo as required.
*The response following the administration of Tensilon® was significantly different from the saline control.
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antivenom and did not require respiratory support. He had a
concentration of circulating venom antigen of 17.6 ng/mL.
Other patients with similarly minimal signs of neurotoxicity had
circulating concentrations of venom antigen ranging between
6.1 and 24.3 ng/mL (mean 13.4 ± 3.6). In those patients with
clinical signs of severe neurotoxicity, venom antigenemia
ranged between 3.5 and 496.5 ng/mL (mean 103.2 ± 16.6;
N = 39). It seems clear that the severity of neurotoxicity is at
least partially dependent on the amount of venom antigen in
the circulation. It was not possible to assess whether there
was any relationship between the concentration of circulat-
ing venom antigen and the speed of onset of neurotoxic
signs because patients were usually admitted many hours
after the onset of their first sign of neurotoxicity.
It is generally accepted that the clinical syndrome of
envenoming by cobras does not include coagulopathy, but in
this study two of the 70 patients had incoagulable blood,
based on a 20WBCT. However, our detailed study of the
possible effects of N. kaouthia venom on human blood
coagulation using TEG® demonstrated no effect on blood
coagulation at venom concentrations exceeding the highest
concentration of venom recorded in any patient bitten by a
monocled cobra (3,300 ng/mL).23 We conclude that the two
aberrant 20WBCT results were probably the result of a
technical error.
The apparent anemia in most patients was not a conse-
quence of the bite: Bangladeshi people are generally anemic
because of a diet short of essential micronutrients.35
The use of ligatures and incisions in the emergency treat-
ment of snakebite is universally condemned as being without
value and potentially harmful.19,36–40 Bangladeshi clinicians
have found it difficult to improve the situation. The positive
response to the use of edrophonium in all patients tested
suggests that the administration of the long-acting anti-
cholinesterase neostigmine could be recommended as a
first aid treatment. More complete training of rural medical
and complementary staff would also enable local medical cen-
ters to provide assisted ventilation to severely envenomed
patients, including oxygen administration and the insertion of
an airway (endotracheal, laryngeal mask, or i-gel supraglottic
airway). Manual respiratory support has been found to be
beneficial in the management of cobra bite.2 During the period
covered by this present study, 27 patients died en route to
CMCH (M. A. Faiz, unpublished data). The problem of
unnecessary fatalities is partly due to the difficulty of providing
high-quality emergency treatment in rural communities but
also to a lack of basic infrastructure and funds to pay for the
transport of severely ill patients to a major referral center. Once
in CMCH, patient mortality was relatively low (2/70) and similar
to case fatalities in similarly specialized facilities elsewhere in
southeast Asia.41 The problem is common across southeast
Asia and a partial solution might be the adoption of motor-
cycle ambulances and similar modes of transport that are
being developed elsewhere.21,42–44
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